ArticleTrials2022

Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.

Timothy L Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.